Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Financing Activities: 2013-2025

Historic Cash from Financing Activities for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $16.3 million.

  • Phibro Animal Health's Cash from Financing Activities rose 155.95% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $252.7 million, marking a year-over-year increase of 778.10%. This contributed to the annual value of $207.1 million for FY2025, which is 3160.49% up from last year.
  • Phibro Animal Health's Cash from Financing Activities amounted to $16.3 million in Q3 2025, which was up 310.34% from -$7.8 million recorded in Q2 2025.
  • Phibro Animal Health's Cash from Financing Activities' 5-year high stood at $276.3 million during Q4 2024, with a 5-year trough of -$32.2 million in Q1 2025.
  • Moreover, its 3-year median value for Cash from Financing Activities was $284,000 (2023), whereas its average is $19.2 million.
  • Data for Phibro Animal Health's Cash from Financing Activities shows a peak YoY increase of 1,979.09% (in 2024) and a maximum YoY decrease of 2,352.85% (in 2024) over the last 5 years.
  • Phibro Animal Health's Cash from Financing Activities (Quarterly) stood at -$14.6 million in 2021, then skyrocketed by 125.49% to $3.7 million in 2022, then slumped by 495.72% to -$14.7 million in 2023, then surged by 1,979.09% to $276.3 million in 2024, then spiked by 155.95% to $16.3 million in 2025.
  • Its last three reported values are $16.3 million in Q3 2025, -$7.8 million for Q2 2025, and -$32.2 million during Q1 2025.